ClinicalTrials.Veeva

Menu

Monitoring Blood Flow and Breathing Using a New Device (RFII) Compared to the Gold Standard Device in Post Operative Cardiac Patients

University of Florida logo

University of Florida

Status

Withdrawn

Conditions

Noninvasive Cardiac Monitoring

Study type

Observational

Funder types

Other
Other U.S. Federal agency
Industry

Identifiers

NCT01434771
20110031

Details and patient eligibility

About

The purpose of this study will be to compare standard of care invasive methods to an FDA approved non-invasive device and a novel wireless non-invasive device, both manufactured by Non-Invasive Medical Technologies Inc., with the goal of correlating the data generated by the novel device to the measurements taken by the standard of care invasive monitors.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years and older
  • Weight - 36-136 Kilograms
  • Height - 1.52 meters - 1.92 meters (5'- 6'4")
  • Scheduled for open heart surgery during the study period

Exclusion criteria

  • ECG lead adhesive allergy or sensitivity
  • Pregnant Patients
  • Prisoners
  • Cognitively impaired
  • Patients requiring mechanical cardiac support, or requirement for hemodialysis
  • Patients not requiring pulmonary artery catheters for medical management.
  • Patients with significant valvular disease will be enrolled if there is no significant post-repair valvular dysfunction as determined by intraoperative transesophageal echocardiography

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems